Lenders report that default rates on secured loans to UK households increased in Q3 2024 and are expected to increase again ...
WJET Erie on MSN16m
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billionUK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...
GSK (LSE: GSK) has settled 93% of Zantac (ranitidine) product liability cases in the USA, agreeing to pay up to $2.2 billion ...
Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S.
Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...
Chinese stock markets returned to winning ways Thursday, closing with solid gains after China's central bank took action to ...
In corporate news, Gsk Plc (GSK.LN) climbed over +5% after the drugmaker agreed to pay up to $2.2 billion to settle U.S. court cases related to its heartburn treatment, Zantac. Italy’s Industrial ...
Zantac settlement should ease investors’ nervousness but long-standing concerns about drugmaker’s pipeline remain ...
Highlights:,GSK PLC has reached a $2.2 billion settlement that addresses 93% of the ongoing litigation related to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback